Tucatinib

  • Part D specialty tier in 80% of formularies (2026Q3)
  • TUKYSA

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Tucatinib: storage and handling

Freezing
Not addressed
Room temperature
at or below 77°F
Label statement
Store TUKYSA at room temperature 68°F to 77°F (20ºC to 25ºC). .
Back into the refrigerator
Not addressed
Light
Not addressed
Shaking
Not addressed

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

Within the label's stated room-temperature allowance (at up to 77°F). Follow the label's instructions for what to do next.

Entered: 1 day at up to 77°F (25°C).

Store TUKYSA at room temperature 68°F to 77°F (20ºC to 25ºC). .
Do not discard desiccant.
Discard any unused tablets 3 months after opening the bottle.
Throw away (discard) any unused tablets 3 months after opening the bottle.

If anything else happened to the product, or you are unsure, Contact the manufacturer at 1-855-473-2436 (the number printed on the label) about this product.

Where the label prints this number
PPI-213411-v04 For more information, call 1-855-473-2436 (1-855-4SEAGEN) or go to www.TUKYSA.com .
All storage statements on the label (6)
  • Store in original container to protect from moisture.
  • Do not discard desiccant.
  • Discard any unused tablets 3 months after opening the bottle.
  • How should I store TUKYSA? .
  • Store TUKYSA at room temperature 68°F to 77°F (20ºC to 25ºC). .
  • Throw away (discard) any unused tablets 3 months after opening the bottle.

FDA label version 9, effective November 4, 2024. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Medicare Part D coverage

100%of plans list it
98%of those: prior authorization
0%step therapy
93%quantity limit
97%specialty tier

5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan

Patient assistance

No manufacturer program page is listed for this drug yet.

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.